[Form 4] SmartKem, Inc. Insider Trading Activity

Rhea-AI Filing Summary

SmartKem, Inc. (SMTK) Form 4 shows Ian Jenks, Chairman & CEO and Director, was granted a stock option on 09/03/2025 to acquire 160,005 shares of Common Stock at an exercise price of $1.16 per share. The option vests 25% on the grant date with the remaining shares vesting in equal monthly installments over 36 months beginning September 3, 2025. The option is exercisable through 09/03/2035. The Form 4 was signed by Ian Jenks on 09/05/2025.

Positive

• Grant recorded to Chairman & CEO (Ian Jenks) showing disclosed alignment of executive compensation with equity ownership
• Clear, standard vesting schedule: 25% immediate vesting then equal monthly installments over 36 months starting 09/03/2025
• Full disclosure of option terms: grant date 09/03/2025, exercise price $1.16, quantity 160,005, expiration 09/03/2035

Negative

• Potential future share issuance when options are exercised (160,005 shares) which could dilute existing shareholders
• Materiality depends on company equity plan context which is not provided in this Form 4, limiting assessment of relative size

Insights

Securities Analyst

TL;DR: Routine executive equity grant: 160,005 options at $1.16, 10-year term, standard multi-year vesting.

This Form 4 discloses a standard stock option award to the companys Chairman & CEO and Director, Ian Jenks. The grant size (160,005 options) and a 10-year expiration are typical for long-term incentive awards. The vesting schedule provides immediate partial vesting (25%) and continued monthly vesting over three years, which aligns long-term executive tenure with potential equity realization. The filing is straightforward and informational for shareholders monitoring insider compensation and potential future share issuance.

Corporate Governance Expert

TL;DR: Disclosure reflects executive compensation action requiring investor monitoring for governance and dilution implications.

The Form 4 clearly identifies the reporting persons roles and the full terms of the option: grant date, exercise price $1.16, amount 160,005 shares, vesting schedule and 2035 expiration. As a governance disclosure, this satisfies Section 16 reporting. Investors concerned with insider alignment and dilution should note the awards size and multi-year vesting but must consult the companys equity plan for context on total authorized dilution and previous grants.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Jenks Ian

(Last) (First) (Middle)

C/O SMARTKEM, MANCHESTER TECHNOLOGY CTR

HEXAGON TOWER DELAUNAYS ROAD, BLACKLEY

(Street)

MANCHESTER X0 M9 8GQ

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
SmartKem, Inc. [ SMTK ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chairman & CEO

3. Date of Earliest Transaction (Month/Day/Year)
09/03/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (right to buy)	$1.16	09/03/2025		A		160,005		(1)	09/03/2035	Common Stock	160,005	$0	160,005	D

Explanation of Responses:

1. The option vests as follows: 25% on the date of grant with the remaining shares to vest in equal monthly installments over a period of 36 months commencing on September 3, 2025 and on the 3rd date of each month thereafter.

	/s/ Ian Jenks	09/05/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Ian Jenks report on the Form 4 for SmartKem (SMTK)?

Ian Jenks reported a grant of a stock option to acquire 160,005 shares of SmartKem common stock on 09/03/2025.

What are the financial terms of the option reported for SMTK?

The option has an exercise price of $1.16 per share and covers 160,005 shares.

When does the option vest and when does it expire for the SMTK grant?

The option vests 25% on the grant date with the remainder vesting in equal monthly installments over 36 months beginning 09/03/2025, and it expires on 09/03/2035.

What positions does the reporting person hold at SmartKem?

The Form 4 lists Ian Jenks as both Chairman & CEO and a Director of SmartKem.

When was the Form 4 signed and filed?

The Form 4 bears the signature of Ian Jenks dated 09/05/2025 and reports the transaction date as 09/03/2025.